中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Viral Diseases
NASH
Cancer
Exploratory Indications
Products&Pipeline
Pipeline
Products
Clinical Trials
Partnership
Investors
Financials & Filing
Presentation Materials
News
Careers
Investors
Financials & Filing
Presentation Materials
2024
2023
2022
2021
2020
2019
2018
2024
2023
2022
2021
2020
2019
2018
Next Day Disclosure Returns - Share Buyback
2024-07-04
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
2024-07-02
Voluntary Announcement - Proposed Share Repurchase under the Repurchase Mandate
2024-07-02
Voluntary Announcement - Gannex Announces Poster Presentation Describing Positive Interim 12-Week Results from Ongoing 52-Week Phase II Clinical Trial of Once-Daily ASC41 in Patients with Biopsy-Confirmed MASH at EASL Congress 2024
2024-06-11
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
2024-06-04
Poll Results of Annual General Meeting Held on May 23, 2024
2024-05-23
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
2024-05-08
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
2024-05-06
Form of Proxy for the 2024 Annual General Meeting
2024-04-26
Notice of 2024 Annual General Meeting
2024-04-26
«
2
3
4
5
»
浙公网安备 33010802003344号
浙ICP备11050387号-1
